|
| Press Releases |
|
 |
|
| Thursday, July 8, 2021 |
|
|
艾德韋宣集團與願景娛樂達成戰略合作 |
| 大中華整合營銷解決方案提供商–艾德韋宣集團控股有限公司（「艾德韋宣」或本「公司」，連同附屬公司總稱本「集團」，股份編號：9919）今日宣佈公司已與願景未來（上海）傳媒科技有限公司（以下簡稱「願景娛樂」）達成戰略合作 more info >> |
|
|
Activation Group and Vision Entertainment Enters into a Strategic Cooperation |
| A provider of integrated marketing solutions in Greater China, Activation Group Holdings Limited ("Activation" or the "Company", collectively, the "Group", stock code: 9919), has entered into a strategic cooperation with Vision Future (Shanghai) Media Technology Co., Ltd.* more info >> |
|
| Tuesday, July 6, 2021 |
|
|
艾德韦宣发盈利预喜公告 |
| 大中华整合营销解决方案提供商–艾德韦宣集团控股有限公司（「艾德韦宣」或本「公司」，连同附属公司总称本「集团」，股份编号：9919）今日发盈利预喜公告。 more info >> |
|
|
艾德韋宣發盈利預喜公告 |
| 大中華整合營銷解決方案提供商–艾德韋宣集團控股有限公司（「艾德韋宣」或本「公司」，連同附屬公司總稱本「集團」，股份編號：9919）今日發盈利預喜公告。 more info >> |
|
|
Activation Group Issues Positive Profit Alert |
| A provider of integrated marketing solutions in Greater China, Activation Group Holdings Limited ("Activation" or the "Company", collectively, the "Group", stock code: 9919), today issued a positive profit alert. Based on a preliminary review of the unaudited management accounts of the Group for the six months ended 30 June 2021 (the "Interim Period") more info >> |
|
| Wednesday, April 28, 2021 |
|
|
艾德韋宣集團與復星時尚集團達成戰略聯盟 |
| 大中華整合營銷解決方案提供商–艾德韋宣集團控股有限公司（「艾德韋宣」或本「公司」，連同附屬公司總稱本「集團」，港交所：9919.HK）今日公佈與復星國際有限公司（港交所：00656.HK）控股子公司復星時尚集團（「FFG」）達成戰略聯盟，以快速捕捉不斷增長的中國奢侈品市場機會。 more info >> |
|
|
Activation Group Forms Strategic Alliance with Fosun Fashion Group |
| A provider of integrated marketing solutions in Greater China, Activation Group Holdings Limited ("Activation" or the "Company", collectively, the "Group", HKEX: 9919.HK) today announced a strategic alliance with Fosun Fashion Group (Cayman) Limited ("Fosun Fashion Group" or "FFG"), a subsidiary of Fosun International Limited (HKEX: 00656.HK), to capitalize on the emerging demand for luxury brands in China. more info >> |
|
| Friday, August 21, 2020 |
|
|
上海雙創投資中心與艾德韋宣正式簽約 |
| 大中華整合營銷集團 – 艾德韋宣集團控股有限公司（「艾德韋宣」或本「公司」，連同附屬公司總稱本「集團」，股份編號：9919）昨天正式與上海雙創投資中心 (「上海雙創」) 簽署合作協定，共同成立總金額為10億元人民幣的產業基金，完善投資、發展泛文化產業，如時尚、體育及娛樂產業、數字及創意行銷範疇，加強品牌及IP運營生態佈局。 more info >> |
|
|
SHIVC and Activation Officially Sign Agreement |
| A provider of integrated marketing solutions in Greater China, Activation Group Holdings Limited ("Activation" or the "Company", collectively, the "Group", stock code: 9919) has officially signed a Limited Partnership Agreement with Shanghai Innovital Capital ("SHIVC") to jointly establish an industry fund amounting to RMB1 billion. more info >> |
|
| Monday, July 27, 2020 |
|
|
上海雙創投資中心與艾德韋宣成立10億元人民幣的產業基金 |
| 大中華整合營銷解決方案提供商 – 艾德韋宣集團控股有限公司（「艾德韋宣」或本「公司」，連同附屬公司總稱本「集團」，股份編號：9919）公佈與上海雙創投資中心 (「上海雙創」)簽署合作備忘錄 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 23:30: JST
|
|
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 22:30 HKT/SGT
|
|
|
Six Factors to Consider When Opting for a Credit Line in Singapore
May 22, 2026 19:05 HKT/SGT
|
|
|
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
May 22, 2026 17:46 HKT/SGT
|
|
|
天辰生物通過聆訊：深耕過敏與自身免疫領域 臨床療效全面領先
May 22, 2026 16:32 HKT/SGT
|
|
|
天辰生物通过聆讯：深耕过敏与自身免疫领域 临床疗效全面领先
May 22, 2026 16:32 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 11:05: JST
|
|
|
雲頂新耀獲主要股東康橋資本增持 全球化佈局有望持續受益
May 22, 2026 10:59 HKT/SGT
|
|
|
GTJAI Won Two Awards at HR Asia 2026
May 22, 2026 10:49 HKT/SGT
|
|
|
國泰君安國際斬獲HR Asia 2026年度兩項大獎
May 22, 2026 10:49 HKT/SGT
|
|
|
国泰君安国际斩获HR Asia 2026年度两项大奖
May 22, 2026 10:49 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 10:05 HKT/SGT
|
|
|
云顶新耀获主要股东康桥资本增持 全球化布局有望持续受益
May 22, 2026 10:05 HKT/SGT
|
|
|
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
May 22, 2026 0:23 JST
|
|
|
Honda to Begin Sales of Super-ONE Compact EV
May 22, 2026 0:16 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
